CELLID CO., LTD.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2026-04-02

Patent Grants:

Last grant date:

2024-09-24

Top Inventors for applications by CELLID CO., LTD.

These are the the leading inventors for applications assigned to CELLID CO., LTD.:

Chang-Yuil Kang 4 Seoul, South Korea
Kwang Soo Shin 2 Seoul, South Korea
Tae Gwon Oh 2 Seoul, South Korea
Insu JEON 1 Seoul, South Korea

Boyeong SONG 1 Seoul, South Korea
Bongju Park 1 Seoul, South Korea
Hyun-Jeong Ko 1 Seoul, South Korea
Seung-Phil SHIN 1 Seoul, South Korea

Yeon-Jeong Kim 1 Changwon-si, South Korea
Jung-Mi Lee 1 Seoul, South Korea

Recent patent applications by CELLID CO., LTD.

CELLID CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-02

US20260091112A1

Human necessities

VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN

#2 | 2024-02-08 ✅ Patent 12,098,384 granted on 2024-09-24

US20240043871A1

Chemistry; metallurgy

Adenoviral vector not including replication competent adenovirus, and use thereof

#3 | 2023-09-21 ✅ Patent 12,622,959 granted on 2026-05-12

US20230293670A1

Human necessities

NOVEL CORONAVIRUS RECOMBINANT SPIKE PROTEIN, POLYNUCLEOTIDE ENCODING SAME, VECTOR COMPRISING POLYNUCLEOTIDE, AND VACCINE FOR PREVENTING OR TREATING CORONAVIRUS INFECTION, COMPRISING VECTOR

#4 | 2009-11-19 ✅ Patent 9,518,126 granted on 2016-12-13

US20090285851A1

Chemistry; metallurgy

Vaccine comprising monocyte or immature myeloid cells (IMC) which were loaded with the ligand of natural killer T cell and antigen

Also check out CELLID CO., LTD.'s (Seoul, South Korea) applicant profile with 4 patent applications submitted.

AssigneeID:

347063 ⎘